Dr. Norbert Kaminski is a professor in the Department of Pharmacology and Toxicology and is the director of the Center for Integrative Toxicology, at Michigan State University. Dr. Kaminski joined the Michigan State faculty in 1993. He was also affiliated with the Medical College of Virginia in their Department of Pharmacology and Toxicology from 1985-1999. He received his B.A. in Chemistry in 1978 from Loyola University in Chicago, Illinois, and his M.S. in Toxicology in 1981 and Ph.D. in Toxicology and Physiology in 1985 from North Carolina State University in Raleigh, North Carolina. Dr. Kaminski has served on a number of advisory panels including National Academy of Science/IOM Review of the Health Effects in Vietnam Veterans of Exposure to Herbicides, 1992-1994; US EPA Science Advisor Board-Dioxin Reassessment Review, 1995; and National Academy of Sciences IOM Study on the Assessment of the Health Implications of Exposure to Dioxins. Dr. Kaminski has also served on a number of peer review panels including US EPA Science Review Panel for Health Research, 1990-92 and NIH ALTX-4 Study Section as a regular member from 1998-03; as an ad hoc member for NIDA, NIEHS, NIOSH, Wellcome Trust, and as Chair of an American Chemistry Council Peer Review Panel in 2001. Dr. Kaminski is presently an Associate Editor for the Journal of Pharmacology and Experimental Therapeutics and is a founding member of the Editorial Board for Nonlinearity in Biology, Toxicology and Medicine and on the editorial board for the journals Toxicology and Journal of Immunotoxicology. Dr. Kaminski served as Treasurer for the Society of Toxicology from 2005-2007. Dr. Kaminski presently serves as a member of Council as well as the Chair of the Membership Committee for the Society on NeuroImmune Pharmacology. He is the author of numerous publications and abstracts. Dr. Kaminski's research is in the general area immunotoxicology. A primary emphasis of his laboratory is directed toward the elucidation of the molecular mechanisms by which drugs and chemicals modulate signal transduction cascades and gene expression during lymphocyte activation and differentiation.